Incidence and predictors of moderate to severe tricuspid regurgitation after dual‐chamber pacemaker implantation. Issue 1 (29th November 2018)

• Record Type: Journal Article
• Authors: Cho, Min Soo; Kim, Jun; Lee, Jung‐Bok; Nam, Gi‐Byoung; Choi, Kee‐Joon; Kim, You‐Ho
• Is Part Of: Pacing and clinical electrophysiology. Volume 42:Issue 1(2019)
• Page Start: 85
• Page End: 92
• Publication Date: 2018-11-29
• Subjects: atrial fibrillation -- pacemaker -- tricuspid regurgitation; Cardiac pacing -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1111/pace.13543
• Languages: English
• ISSNs: 0147-8389

Abstract

Abstract: Introduction: The incidence and predictors of tricuspid regurgitation (TR) after permanent pacemaker (PM) implantations have not been well evaluated. We attempted to determine TR's natural course and predictors, especially focusing on the influence of atrial fibrillation (AF). Methods: Data from 530 patients with dual‐chamber PMs were evaluated. The main study outcomes were moderate to severe TR and isolated TR (moderate to severe TR without other structural heart diseases [SHDs]) in follow‐up echocardiography. Results: Over a median follow‐up period of 7.6 years, moderate to severe TR developed in 14.5% patients. Of those, concomitant SHD was observed in 51.9% of patients, and 48.1% presented with isolated TR. A multivariable analysis identified the independent predictors of moderate to severe TR (diabetes mellitus [DM], chronic lung disease, preexisting mild TR, peripheral artery disease, moderate to severe aortic regurgitation, and persistent AF [PeAF]) and isolated TR (DM, preexisting mild TR, and PeAF). PeAF (n = 67, 12.6%) was an independent predictor of both moderate to severe TR (hazard ratio [HR] 2.59, 95% confidence interval [CI]: 1.22–5.51) and isolated TR (HR 4.54, 95% CI: 1.60–12.90). The patients with PeAF exhibited a higher incidence of moderate to severe TR (21.8% vs 12.9% vs 11.6% PeAF, paroxysmal AF, and without AF, respectively) and isolated TR (18.6% vs 6.6% vs 4.2%, respectively) during the follow‐up. Conclusion: Moderate to severe TR after PM implantations developed with or without the influence of concomitant SHD. Patients with PeAF exhibited a higher risk of moderate to severe TR after PM implantations.